MYD88 and cardiovascular disorder: All of these drugs showed varying levels of activity on TLR/MyD88 signalling, and have varying pharmacodynamic properties, therefore could be useful for specific forms of cardiovascular diseases (CVD) depending on the exact contributions of MyD88.